

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | extracellular fibril organization (GO:0043206) | 9.72057778 |
| 2 | keratan sulfate catabolic process (GO:0042340) | 9.40347709 |
| 3 | protein heterotrimerization (GO:0070208) | 8.62211823 |
| 4 | fibril organization (GO:0097435) | 8.32505037 |
| 5 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 7.32947403 |
| 6 | collagen fibril organization (GO:0030199) | 6.74508817 |
| 7 | sequestering of extracellular ligand from receptor (GO:0035581) | 6.32172424 |
| 8 | extracellular matrix assembly (GO:0085029) | 5.79963384 |
| 9 | dermatan sulfate biosynthetic process (GO:0030208) | 5.66134252 |
| 10 | bone trabecula formation (GO:0060346) | 5.48947779 |
| 11 | dermatan sulfate metabolic process (GO:0030205) | 5.17277429 |
| 12 | positive regulation of osteoblast proliferation (GO:0033690) | 5.02032459 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 4.87717739 |
| 14 | collagen metabolic process (GO:0032963) | 4.87567051 |
| 15 | growth hormone secretion (GO:0030252) | 4.67452072 |
| 16 | multicellular organismal macromolecule metabolic process (GO:0044259) | 4.65663847 |
| 17 | collagen catabolic process (GO:0030574) | 4.61409092 |
| 18 | atrioventricular valve morphogenesis (GO:0003181) | 4.53437423 |
| 19 | regulation of sequestering of triglyceride (GO:0010889) | 4.48341942 |
| 20 | multicellular organismal metabolic process (GO:0044236) | 4.45299323 |
| 21 | multicellular organismal catabolic process (GO:0044243) | 4.32172170 |
| 22 | negative regulation of biomineral tissue development (GO:0070168) | 4.31623565 |
| 23 | keratan sulfate biosynthetic process (GO:0018146) | 4.19007508 |
| 24 | peripheral nervous system axon ensheathment (GO:0032292) | 4.05579288 |
| 25 | myelination in peripheral nervous system (GO:0022011) | 4.05579288 |
| 26 | triglyceride catabolic process (GO:0019433) | 4.03860321 |
| 27 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 4.03503336 |
| 28 | glomerulus development (GO:0032835) | 4.01701980 |
| 29 | endocardial cushion morphogenesis (GO:0003203) | 3.99514664 |
| 30 | myoblast migration (GO:0051451) | 3.99148640 |
| 31 | venous blood vessel morphogenesis (GO:0048845) | 3.97658279 |
| 32 | extracellular matrix disassembly (GO:0022617) | 3.97579867 |
| 33 | skeletal muscle adaptation (GO:0043501) | 3.95790183 |
| 34 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.89205403 |
| 35 | barbed-end actin filament capping (GO:0051016) | 3.84871593 |
| 36 | plasma membrane repair (GO:0001778) | 3.82829451 |
| 37 | sulfur compound catabolic process (GO:0044273) | 3.82298861 |
| 38 | detection of molecule of bacterial origin (GO:0032490) | 3.79705533 |
| 39 | skin morphogenesis (GO:0043589) | 3.78643232 |
| 40 | negative regulation of heart growth (GO:0061117) | 3.72015235 |
| 41 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.72015235 |
| 42 | metanephric mesenchyme development (GO:0072075) | 3.69761326 |
| 43 | endodermal cell differentiation (GO:0035987) | 3.68663991 |
| 44 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.66382795 |
| 45 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 3.65318127 |
| 46 | cellular response to epinephrine stimulus (GO:0071872) | 3.64809805 |
| 47 | opsonization (GO:0008228) | 3.64579731 |
| 48 | vocalization behavior (GO:0071625) | 3.64301858 |
| 49 | keratan sulfate metabolic process (GO:0042339) | 3.61536433 |
| 50 | cardiac myofibril assembly (GO:0055003) | 3.59562407 |
| 51 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.59448491 |
| 52 | epithelial cell-cell adhesion (GO:0090136) | 3.59322109 |
| 53 | acylglycerol catabolic process (GO:0046464) | 3.58510201 |
| 54 | neutral lipid catabolic process (GO:0046461) | 3.58510201 |
| 55 | chondroitin sulfate catabolic process (GO:0030207) | 3.57932435 |
| 56 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.56415067 |
| 57 | myofibril assembly (GO:0030239) | 3.56040711 |
| 58 | endothelial cell morphogenesis (GO:0001886) | 3.55510250 |
| 59 | fatty acid transmembrane transport (GO:1902001) | 3.50650114 |
| 60 | extracellular matrix organization (GO:0030198) | 3.50513204 |
| 61 | extracellular structure organization (GO:0043062) | 3.49061559 |
| 62 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.45597648 |
| 63 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.41959761 |
| 64 | growth hormone receptor signaling pathway (GO:0060396) | 3.40304671 |
| 65 | gonadal mesoderm development (GO:0007506) | 3.38332456 |
| 66 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 3.35492308 |
| 67 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.34625910 |
| 68 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.34584461 |
| 69 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.29563386 |
| 70 | negative regulation of stress fiber assembly (GO:0051497) | 3.28431453 |
| 71 | camera-type eye morphogenesis (GO:0048593) | 3.27751064 |
| 72 | carnitine shuttle (GO:0006853) | 3.27691725 |
| 73 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.27223652 |
| 74 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.23924013 |
| 75 | extracellular negative regulation of signal transduction (GO:1900116) | 3.22975472 |
| 76 | extracellular regulation of signal transduction (GO:1900115) | 3.22975472 |
| 77 | oxygen transport (GO:0015671) | 3.21935819 |
| 78 | ovulation from ovarian follicle (GO:0001542) | 3.20940192 |
| 79 | trabecula formation (GO:0060343) | 3.20814947 |
| 80 | mesenchyme morphogenesis (GO:0072132) | 3.20558708 |
| 81 | negative regulation of Rho protein signal transduction (GO:0035024) | 3.19979159 |
| 82 | endocrine hormone secretion (GO:0060986) | 3.18833078 |
| 83 | kidney mesenchyme development (GO:0072074) | 3.18182582 |
| 84 | protein trimerization (GO:0070206) | 3.16674839 |
| 85 | positive regulation of cholesterol efflux (GO:0010875) | 3.15337187 |
| 86 | glycosaminoglycan catabolic process (GO:0006027) | 3.14476688 |
| 87 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.14068029 |
| 88 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.13416504 |
| 89 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.13154823 |
| 90 | cellular response to growth hormone stimulus (GO:0071378) | 3.13000755 |
| 91 | glomerular basement membrane development (GO:0032836) | 3.11687609 |
| 92 | response to epinephrine (GO:0071871) | 3.11542049 |
| 93 | actin-myosin filament sliding (GO:0033275) | 3.09769244 |
| 94 | muscle filament sliding (GO:0030049) | 3.09769244 |
| 95 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 3.07327990 |
| 96 | regulation of plasminogen activation (GO:0010755) | 3.05351607 |
| 97 | muscle cell migration (GO:0014812) | 3.04635410 |
| 98 | cell migration involved in heart development (GO:0060973) | 3.04305236 |
| 99 | peptide cross-linking (GO:0018149) | 3.03898821 |
| 100 | regulation of macrophage cytokine production (GO:0010935) | 3.03791747 |
| 101 | regulation of cardiac muscle hypertrophy (GO:0010611) | 3.03008016 |
| 102 | muscle hypertrophy (GO:0014896) | 3.02769251 |
| 103 | behavioral response to pain (GO:0048266) | 2.99957989 |
| 104 | regulation of muscle hypertrophy (GO:0014743) | 2.97368386 |
| 105 | creatine metabolic process (GO:0006600) | 2.97360217 |
| 106 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.96880260 |
| 107 | fatty acid homeostasis (GO:0055089) | 2.96720430 |
| 108 | protein retention in ER lumen (GO:0006621) | 2.96483996 |
| 109 | polyol transport (GO:0015791) | 2.96115670 |
| 110 | ethanol oxidation (GO:0006069) | 2.95920674 |
| 111 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.95780108 |
| 112 | positive regulation of fatty acid oxidation (GO:0046321) | 2.94063725 |
| 113 | adhesion of symbiont to host cell (GO:0044650) | 2.93481142 |
| 114 | virion attachment to host cell (GO:0019062) | 2.93481142 |
| 115 | substrate-dependent cell migration (GO:0006929) | 2.92972753 |
| 116 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.92377342 |
| 117 | aminoglycan catabolic process (GO:0006026) | 2.90771763 |
| 118 | fibroblast migration (GO:0010761) | 2.90043884 |
| 119 | basement membrane organization (GO:0071711) | 2.88895951 |
| 120 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.87181527 |
| 121 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.86410234 |
| 122 | NADH metabolic process (GO:0006734) | 2.86054245 |
| 123 | regulation of p38MAPK cascade (GO:1900744) | 2.85238885 |
| 124 | cGMP-mediated signaling (GO:0019934) | 2.84936576 |
| 125 | glomerular filtration (GO:0003094) | 2.82728353 |
| 126 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.82590226 |
| 127 | regulation of cholesterol storage (GO:0010885) | 2.80451475 |
| 128 | complement activation, alternative pathway (GO:0006957) | 2.80027445 |
| 129 | positive regulation of glucose import (GO:0046326) | 2.77161417 |
| 130 | regulation of interleukin-8 secretion (GO:2000482) | 2.77034359 |
| 131 | striated muscle hypertrophy (GO:0014897) | 2.76929520 |
| 132 | cellular response to BMP stimulus (GO:0071773) | 2.76722052 |
| 133 | response to BMP (GO:0071772) | 2.76722052 |
| 134 | positive regulation of glomerulus development (GO:0090193) | 2.76700031 |
| 135 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.75696189 |
| 136 | glycosaminoglycan biosynthetic process (GO:0006024) | 2.74866688 |
| 137 | actin-mediated cell contraction (GO:0070252) | 2.74798521 |
| 138 | regulation of skeletal muscle contraction (GO:0014819) | 2.74416207 |
| 139 | regulation of phospholipase A2 activity (GO:0032429) | 2.73420862 |
| 140 | blood vessel maturation (GO:0001955) | 2.72794876 |
| 141 | aminoglycan biosynthetic process (GO:0006023) | 2.72428904 |
| 142 | adhesion of symbiont to host (GO:0044406) | 2.72250721 |
| 143 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.71005975 |
| 144 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.70920903 |
| 145 | chondrocyte proliferation (GO:0035988) | 2.69229964 |
| 146 | non-canonical Wnt signaling pathway (GO:0035567) | 2.68828974 |
| 147 | negative regulation of granulocyte differentiation (GO:0030853) | 2.68567037 |
| 148 | negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512) | 2.68493088 |
| 149 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.68140690 |
| 150 | arginine catabolic process (GO:0006527) | 2.67472737 |
| 151 | positive regulation of glycolytic process (GO:0045821) | 2.66056550 |
| 152 | positive regulation of lipid storage (GO:0010884) | 2.65094249 |
| 153 | valine metabolic process (GO:0006573) | 2.64955327 |
| 154 | phagocytosis, recognition (GO:0006910) | 2.64781292 |
| 155 | negative regulation of gluconeogenesis (GO:0045721) | 2.64485819 |
| 156 | positive regulation of cholesterol transport (GO:0032376) | 2.63336295 |
| 157 | positive regulation of sterol transport (GO:0032373) | 2.63336295 |
| 158 | protein localization to cell surface (GO:0034394) | 2.62444632 |
| 159 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.60447300 |
| 160 | actin filament-based movement (GO:0030048) | 2.60443995 |
| 161 | apoptotic cell clearance (GO:0043277) | 2.57384385 |
| 162 | positive regulation of p38MAPK cascade (GO:1900745) | 2.54312078 |
| 163 | skeletal muscle contraction (GO:0003009) | 2.51517508 |
| 164 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.50625569 |
| 165 | glycerolipid catabolic process (GO:0046503) | 2.49433011 |
| 166 | renal filtration (GO:0097205) | 2.48977789 |
| 167 | sarcomere organization (GO:0045214) | 2.47397145 |
| 168 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.45784833 |
| 169 | positive regulation of metanephros development (GO:0072216) | 2.44724596 |
| 170 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.43961779 |
| 171 | striated muscle adaptation (GO:0014888) | 2.43034823 |
| 172 | regulation of muscle adaptation (GO:0043502) | 2.42388759 |
| 173 | regulation of smooth muscle cell migration (GO:0014910) | 2.42357889 |
| 174 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.41395063 |
| 175 | transcytosis (GO:0045056) | 2.39652930 |
| 176 | lipid storage (GO:0019915) | 2.39395014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 6.47699274 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.23562433 |
| 3 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 4.03446829 |
| 4 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.91932697 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.86414480 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.85915102 |
| 7 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.83927409 |
| 8 | CJUN_26792858_Chip-Seq_BT549_Human | 2.75080861 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.55016613 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.45364252 |
| 11 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.30243042 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.29873653 |
| 13 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.21729436 |
| 14 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.09286608 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.08968426 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.08393103 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.03207368 |
| 18 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.90714752 |
| 19 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.89705311 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.89333761 |
| 21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88185545 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.82163853 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.79056337 |
| 24 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74700226 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.66495611 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.62894797 |
| 27 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62606744 |
| 28 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.56297709 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.53363826 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.53156222 |
| 31 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.53156222 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.51840134 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.48013005 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.44271018 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.44271018 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42710386 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.41890398 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.41746900 |
| 39 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40420430 |
| 40 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40341219 |
| 41 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.39524643 |
| 42 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.38045731 |
| 43 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.38045731 |
| 44 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.38039048 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.37190248 |
| 46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.36568490 |
| 47 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35269115 |
| 48 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33784532 |
| 49 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.32057993 |
| 50 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.30772967 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27163985 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.25456204 |
| 53 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21223932 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18629181 |
| 55 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.16413131 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.15541009 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.15418935 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.15221604 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15216538 |
| 60 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.14939199 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13003229 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.12404151 |
| 63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11953251 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11703427 |
| 65 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11312785 |
| 66 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10161439 |
| 67 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09306013 |
| 68 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.08855271 |
| 69 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08475916 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.07802035 |
| 71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07771612 |
| 72 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.06880306 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05990262 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.05896949 |
| 75 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04465936 |
| 76 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.04269005 |
| 77 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.03623120 |
| 78 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.03542622 |
| 79 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03407596 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03172602 |
| 81 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.02887373 |
| 82 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02616204 |
| 83 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02231210 |
| 84 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.00835680 |
| 85 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99634921 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99426417 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98086595 |
| 88 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97689466 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97623517 |
| 90 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96949198 |
| 91 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.94990984 |
| 92 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.94305050 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93729784 |
| 94 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.92675364 |
| 95 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92478666 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92001694 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91846145 |
| 98 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90930305 |
| 99 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.90589455 |
| 100 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89663377 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89308850 |
| 102 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.89110010 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.88157515 |
| 104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.88157515 |
| 105 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.88122700 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87899259 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87863614 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87209034 |
| 109 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86860990 |
| 110 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.86792371 |
| 111 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.86785051 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86341726 |
| 113 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.86275786 |
| 114 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85522963 |
| 115 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83838022 |
| 116 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83250708 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.81963852 |
| 118 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81749159 |
| 119 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.80306226 |
| 120 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.80239229 |
| 121 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.79946467 |
| 122 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78976697 |
| 123 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.78957861 |
| 124 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.78866365 |
| 125 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.78395839 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.78299170 |
| 127 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.78151047 |
| 128 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77547321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 8.55141856 |
| 2 | MP0005275_abnormal_skin_tensile | 8.52867688 |
| 3 | MP0005670_abnormal_white_adipose | 4.30764381 |
| 4 | MP0001958_emphysema | 3.59037079 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.98957906 |
| 6 | MP0002108_abnormal_muscle_morphology | 2.87602044 |
| 7 | MP0003279_aneurysm | 2.75553866 |
| 8 | MP0005666_abnormal_adipose_tissue | 2.66155704 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.48636557 |
| 10 | MP0002060_abnormal_skin_morphology | 2.46782606 |
| 11 | MP0000751_myopathy | 2.42081648 |
| 12 | MP0001661_extended_life_span | 2.24789783 |
| 13 | MP0005375_adipose_tissue_phenotype | 2.05991568 |
| 14 | MP0005508_abnormal_skeleton_morphology | 2.02506115 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 10.6568862 |
| 16 | MP0004272_abnormal_basement_membrane | 1.96357807 |
| 17 | MP0006054_spinal_hemorrhage | 1.87728114 |
| 18 | MP0005171_absent_coat_pigmentation | 1.76437434 |
| 19 | MP0002971_abnormal_brown_adipose | 1.70951114 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.70257560 |
| 21 | MP0010368_abnormal_lymphatic_system | 1.70221893 |
| 22 | MP0003283_abnormal_digestive_organ | 1.64055867 |
| 23 | MP0000749_muscle_degeneration | 1.56125167 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.55642770 |
| 25 | MP0009384_cardiac_valve_regurgitation | 1.47808096 |
| 26 | MP0002295_abnormal_pulmonary_circulatio | 1.45171895 |
| 27 | MP0009115_abnormal_fat_cell | 1.36506507 |
| 28 | MP0004134_abnormal_chest_morphology | 1.34548100 |
| 29 | MP0001243_abnormal_dermal_layer | 1.34334738 |
| 30 | MP0005369_muscle_phenotype | 1.32521671 |
| 31 | MP0002933_joint_inflammation | 1.24039219 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.19076284 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 1.17838908 |
| 34 | MP0005390_skeleton_phenotype | 1.16349938 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.13547391 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.13190840 |
| 37 | MP0001542_abnormal_bone_strength | 1.13100459 |
| 38 | MP0009250_abnormal_appendicular_skeleto | 1.11274049 |
| 39 | MP0002876_abnormal_thyroid_physiology | 1.10458943 |
| 40 | MP0005330_cardiomyopathy | 1.06820673 |
| 41 | MP0003959_abnormal_lean_body | 1.05642858 |
| 42 | MP0000750_abnormal_muscle_regeneration | 1.01438192 |
| 43 | MP0000747_muscle_weakness | 0.98570493 |
| 44 | MP0003646_muscle_fatigue | 0.97272027 |
| 45 | MP0004087_abnormal_muscle_fiber | 0.95955464 |
| 46 | MP0002106_abnormal_muscle_physiology | 0.95360698 |
| 47 | MP0002254_reproductive_system_inflammat | 0.94548113 |
| 48 | MP0005023_abnormal_wound_healing | 0.94247804 |
| 49 | MP0000343_altered_response_to | 0.92707812 |
| 50 | MP0010386_abnormal_urinary_bladder | 0.91936422 |
| 51 | MP0003252_abnormal_bile_duct | 0.89078713 |
| 52 | MP0003724_increased_susceptibility_to | 0.88556447 |
| 53 | MP0000759_abnormal_skeletal_muscle | 0.88276137 |
| 54 | MP0002970_abnormal_white_adipose | 0.83268913 |
| 55 | MP0003045_fibrosis | 0.83008200 |
| 56 | MP0005334_abnormal_fat_pad | 0.82515108 |
| 57 | MP0010329_abnormal_lipoprotein_level | 0.82268302 |
| 58 | MP0005620_abnormal_muscle_contractility | 0.81215813 |
| 59 | MP0005595_abnormal_vascular_smooth | 0.77075912 |
| 60 | MP0002168_other_aberrant_phenotype | 0.76479621 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.74713553 |
| 62 | MP0000163_abnormal_cartilage_morphology | 0.74297209 |
| 63 | MP0002127_abnormal_cardiovascular_syste | 0.72700854 |
| 64 | MP0005535_abnormal_body_temperature | 0.72240591 |
| 65 | MP0005388_respiratory_system_phenotype | 0.71812142 |
| 66 | MP0002133_abnormal_respiratory_system | 0.71812142 |
| 67 | MP0005385_cardiovascular_system_phenoty | 0.70082864 |
| 68 | MP0001544_abnormal_cardiovascular_syste | 0.70082864 |
| 69 | MP0010771_integument_phenotype | 0.68594721 |
| 70 | MP0004215_abnormal_myocardial_fiber | 0.68033235 |
| 71 | MP0003448_altered_tumor_morphology | 0.67688198 |
| 72 | MP0000733_abnormal_muscle_development | 0.67224574 |
| 73 | MP0004084_abnormal_cardiac_muscle | 0.67125774 |
| 74 | MP0000249_abnormal_blood_vessel | 0.66260718 |
| 75 | MP0002972_abnormal_cardiac_muscle | 0.66202033 |
| 76 | MP0005623_abnormal_meninges_morphology | 0.65260890 |
| 77 | MP0002896_abnormal_bone_mineralization | 0.64727835 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.64403019 |
| 79 | MP0004036_abnormal_muscle_relaxation | 0.63868796 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.63780195 |
| 81 | MP0002115_abnormal_skeleton_extremities | 0.63628276 |
| 82 | MP0001533_abnormal_skeleton_physiology | 0.63076859 |
| 83 | MP0004858_abnormal_nervous_system | 0.62408741 |
| 84 | MP0002128_abnormal_blood_circulation | 0.61366826 |
| 85 | MP0003115_abnormal_respiratory_system | 0.61285379 |
| 86 | MP0005165_increased_susceptibility_to | 0.61281611 |
| 87 | MP0002118_abnormal_lipid_homeostasis | 0.60887853 |
| 88 | MP0004130_abnormal_muscle_cell | 0.60727964 |
| 89 | MP0000767_abnormal_smooth_muscle | 0.60520176 |
| 90 | MP0004484_altered_response_of | 0.60335696 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.59815212 |
| 92 | MP0003868_abnormal_feces_composition | 0.59487041 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.57456091 |
| 94 | MP0005448_abnormal_energy_balance | 0.57113021 |
| 95 | MP0006138_congestive_heart_failure | 0.56462825 |
| 96 | MP0003948_abnormal_gas_homeostasis | 0.55805906 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.55702285 |
| 98 | MP0002113_abnormal_skeleton_development | 0.55278128 |
| 99 | MP0003191_abnormal_cellular_cholesterol | 0.55190084 |
| 100 | MP0002932_abnormal_joint_morphology | 0.55000108 |
| 101 | MP0005164_abnormal_response_to | 0.54648083 |
| 102 | MP0003075_altered_response_to | 0.54390643 |
| 103 | MP0002332_abnormal_exercise_endurance | 0.54341108 |
| 104 | MP0004883_abnormal_blood_vessel | 0.53575060 |
| 105 | MP0008004_abnormal_stomach_pH | 0.53375859 |
| 106 | MP0002269_muscular_atrophy | 0.52775266 |
| 107 | MP0003385_abnormal_body_wall | 0.52472226 |
| 108 | MP0000534_abnormal_ureter_morphology | 0.51722509 |
| 109 | MP0002166_altered_tumor_susceptibility | 0.50125537 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.49618551 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.49510578 |
| 112 | MP0001175_abnormal_lung_morphology | 0.49488704 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.49435224 |
| 114 | MP0008775_abnormal_heart_ventricle | 0.49429884 |
| 115 | MP0010630_abnormal_cardiac_muscle | 0.49331718 |
| 116 | MP0003795_abnormal_bone_structure | 0.48529249 |
| 117 | MP0001879_abnormal_lymphatic_vessel | 0.48183367 |
| 118 | MP0003091_abnormal_cell_migration | 0.47389431 |
| 119 | MP0003828_pulmonary_edema | 0.43577826 |
| 120 | MP0002006_tumorigenesis | 0.42747190 |
| 121 | MP0001614_abnormal_blood_vessel | 0.42320285 |
| 122 | MP0001177_atelectasis | 0.41315926 |
| 123 | MP0000266_abnormal_heart_morphology | 0.41184035 |
| 124 | MP0005166_decreased_susceptibility_to | 0.39655715 |
| 125 | MP0009931_abnormal_skin_appearance | 0.37877762 |
| 126 | MP0005193_abnormal_anterior_eye | 0.37399063 |
| 127 | MP0005076_abnormal_cell_differentiation | 0.36905759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 9.10650850 |
| 2 | Broad metatarsal (HP:0001783) | 6.86121547 |
| 3 | Premature rupture of membranes (HP:0001788) | 6.53103921 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.46605066 |
| 5 | Increased connective tissue (HP:0009025) | 5.21419030 |
| 6 | Aortic dissection (HP:0002647) | 4.89787219 |
| 7 | Ankle contracture (HP:0006466) | 4.89725587 |
| 8 | Soft skin (HP:0000977) | 4.61827324 |
| 9 | Shallow orbits (HP:0000586) | 4.48608576 |
| 10 | Round ear (HP:0100830) | 4.48456864 |
| 11 | Aortic aneurysm (HP:0004942) | 4.27475186 |
| 12 | Follicular hyperkeratosis (HP:0007502) | 4.26973090 |
| 13 | Bladder diverticulum (HP:0000015) | 4.17672624 |
| 14 | Cerebral aneurysm (HP:0004944) | 4.14449379 |
| 15 | Dilatation of the ascending aorta (HP:0005111) | 4.12972027 |
| 16 | Flat cornea (HP:0007720) | 3.97317635 |
| 17 | Striae distensae (HP:0001065) | 3.80591780 |
| 18 | Spinal rigidity (HP:0003306) | 3.78894043 |
| 19 | Slender build (HP:0001533) | 3.70669854 |
| 20 | Mitral valve prolapse (HP:0001634) | 3.69459423 |
| 21 | Oligomenorrhea (HP:0000876) | 3.68027525 |
| 22 | Atrophic scars (HP:0001075) | 3.64392622 |
| 23 | Muscle fiber splitting (HP:0003555) | 3.56298136 |
| 24 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.56122900 |
| 25 | Fragile skin (HP:0001030) | 3.52731491 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.44004956 |
| 27 | Thin bony cortex (HP:0002753) | 3.37954894 |
| 28 | Spondylolisthesis (HP:0003302) | 3.35927537 |
| 29 | Mitral stenosis (HP:0001718) | 3.33436293 |
| 30 | Neonatal short-limb short stature (HP:0008921) | 3.30140419 |
| 31 | Vertebral compression fractures (HP:0002953) | 3.27602191 |
| 32 | Subacute progressive viral hepatitis (HP:0006572) | 3.24378992 |
| 33 | Genu recurvatum (HP:0002816) | 3.23197383 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.20784035 |
| 35 | Wormian bones (HP:0002645) | 2.98378397 |
| 36 | Broad ribs (HP:0000885) | 2.97244902 |
| 37 | Hyperextensible skin (HP:0000974) | 2.96918014 |
| 38 | Pulmonary artery stenosis (HP:0004415) | 2.96589855 |
| 39 | Wrist flexion contracture (HP:0001239) | 2.95505620 |
| 40 | Biconcave vertebral bodies (HP:0004586) | 2.92630392 |
| 41 | Abnormal delivery (HP:0001787) | 2.85916517 |
| 42 | Peritonitis (HP:0002586) | 2.85195820 |
| 43 | Blue sclerae (HP:0000592) | 2.85137810 |
| 44 | Spinal cord compression (HP:0002176) | 2.85088026 |
| 45 | Overgrowth (HP:0001548) | 2.83849670 |
| 46 | Neck muscle weakness (HP:0000467) | 2.75669791 |
| 47 | Abnormality of complement system (HP:0005339) | 2.75095895 |
| 48 | Mitral regurgitation (HP:0001653) | 2.72912868 |
| 49 | Mild short stature (HP:0003502) | 2.70044291 |
| 50 | Hypoplasia of the iris (HP:0007676) | 2.66268811 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.65628486 |
| 52 | Joint stiffness (HP:0001387) | 2.63925351 |
| 53 | Cervical subluxation (HP:0003308) | 2.62881369 |
| 54 | Vascular tortuosity (HP:0004948) | 2.60973788 |
| 55 | Muscle fiber inclusion bodies (HP:0100299) | 2.59719076 |
| 56 | Ectopia lentis (HP:0001083) | 2.58840170 |
| 57 | Aortic valve stenosis (HP:0001650) | 2.57468541 |
| 58 | Alopecia of scalp (HP:0002293) | 2.53653817 |
| 59 | Right ventricular cardiomyopathy (HP:0011663) | 2.50709221 |
| 60 | Abnormality of the calf musculature (HP:0001430) | 2.48285914 |
| 61 | Small epiphyses (HP:0010585) | 2.48123847 |
| 62 | Joint laxity (HP:0001388) | 2.47294489 |
| 63 | Osteolytic defects of the hand bones (HP:0009699) | 2.47015061 |
| 64 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47015061 |
| 65 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.46792981 |
| 66 | Bulbar palsy (HP:0001283) | 2.44575757 |
| 67 | Exercise-induced myalgia (HP:0003738) | 2.43236426 |
| 68 | Calf muscle hypertrophy (HP:0008981) | 2.42430239 |
| 69 | Disproportionate tall stature (HP:0001519) | 2.41614203 |
| 70 | Infantile muscular hypotonia (HP:0008947) | 2.37491622 |
| 71 | Abnormality of dentin (HP:0010299) | 2.37221590 |
| 72 | Myotonia (HP:0002486) | 2.35898845 |
| 73 | Aortic regurgitation (HP:0001659) | 2.35830255 |
| 74 | Camptodactyly of toe (HP:0001836) | 2.34632303 |
| 75 | Acanthosis nigricans (HP:0000956) | 2.34617893 |
| 76 | Decreased subcutaneous fat (HP:0001002) | 2.30597635 |
| 77 | Aneurysm (HP:0002617) | 2.29242688 |
| 78 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.28203265 |
| 79 | Generalized amyotrophy (HP:0003700) | 2.27435832 |
| 80 | Rimmed vacuoles (HP:0003805) | 2.26809865 |
| 81 | Arterial tortuosity (HP:0005116) | 2.26321520 |
| 82 | Beaking of vertebral bodies (HP:0004568) | 2.24956464 |
| 83 | Lipoatrophy (HP:0100578) | 2.22951235 |
| 84 | Hyporeflexia of lower limbs (HP:0002600) | 2.22493515 |
| 85 | Esophageal neoplasm (HP:0100751) | 2.21049973 |
| 86 | Neoplasm of head and neck (HP:0012288) | 2.21049973 |
| 87 | Abnormality of the acetabulum (HP:0003170) | 2.20582778 |
| 88 | Sudden death (HP:0001699) | 2.20459763 |
| 89 | Nemaline bodies (HP:0003798) | 2.18637849 |
| 90 | Scapular winging (HP:0003691) | 2.18631371 |
| 91 | Exercise-induced muscle cramps (HP:0003710) | 2.18527654 |
| 92 | Bowel diverticulosis (HP:0005222) | 2.16118527 |
| 93 | Ovoid vertebral bodies (HP:0003300) | 2.15854034 |
| 94 | Redundant skin (HP:0001582) | 2.15407650 |
| 95 | Systemic lupus erythematosus (HP:0002725) | 2.14630287 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.14440062 |
| 97 | Emphysema (HP:0002097) | 2.13138431 |
| 98 | Rectal prolapse (HP:0002035) | 2.12399016 |
| 99 | Abnormality of the ischium (HP:0003174) | 2.11893449 |
| 100 | Osteoarthritis (HP:0002758) | 2.10557356 |
| 101 | Limited hip movement (HP:0008800) | 2.09761232 |
| 102 | EMG: myopathic abnormalities (HP:0003458) | 2.06030840 |
| 103 | Elbow flexion contracture (HP:0002987) | 2.03651856 |
| 104 | Proximal amyotrophy (HP:0007126) | 2.03435165 |
| 105 | Ulnar deviation of the wrist (HP:0003049) | 2.02341735 |
| 106 | Ventricular tachycardia (HP:0004756) | 2.00194079 |
| 107 | Hip contracture (HP:0003273) | 1.99418148 |
| 108 | Broad palm (HP:0001169) | 1.99171933 |
| 109 | Lymphangioma (HP:0100764) | 1.98867417 |
| 110 | Wide anterior fontanel (HP:0000260) | 1.96906969 |
| 111 | Hypoplasia of the odontoid process (HP:0003311) | 1.96522405 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.94714567 |
| 113 | Venous abnormality (HP:0002624) | 1.91831906 |
| 114 | Abnormality of the anterior chamber (HP:0000593) | 1.91602581 |
| 115 | Difficulty running (HP:0009046) | 1.87157903 |
| 116 | Distal arthrogryposis (HP:0005684) | 1.86793963 |
| 117 | Amyloidosis (HP:0011034) | 1.86556575 |
| 118 | Irregular vertebral endplates (HP:0003301) | 1.86343918 |
| 119 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.85846142 |
| 120 | Venous insufficiency (HP:0005293) | 1.84828633 |
| 121 | Gowers sign (HP:0003391) | 1.83886161 |
| 122 | Breech presentation (HP:0001623) | 1.83302448 |
| 123 | Myopathic facies (HP:0002058) | 1.83108092 |
| 124 | Narrow nasal bridge (HP:0000446) | 1.82643180 |
| 125 | Calcaneovalgus deformity (HP:0001848) | 1.81496821 |
| 126 | Frequent falls (HP:0002359) | 1.81005090 |
| 127 | Complement deficiency (HP:0004431) | 1.80157592 |
| 128 | Distal lower limb muscle weakness (HP:0009053) | 1.78118715 |
| 129 | Limb-girdle muscle weakness (HP:0003325) | 1.76727969 |
| 130 | Joint contractures involving the joints of the feet (HP:0100492) | 1.75200933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.84029332 |
| 2 | TTN | 4.01433620 |
| 3 | TGFBR2 | 3.48351697 |
| 4 | EPHA3 | 2.74530206 |
| 5 | DDR2 | 2.69658280 |
| 6 | PDGFRA | 2.59231961 |
| 7 | STK24 | 2.58997292 |
| 8 | SIK1 | 2.54355481 |
| 9 | ERN1 | 2.42261922 |
| 10 | TIE1 | 2.36943220 |
| 11 | EEF2K | 2.26041377 |
| 12 | EPHB1 | 2.21232975 |
| 13 | TRIB3 | 2.20081191 |
| 14 | MAP3K6 | 2.13313695 |
| 15 | STK38L | 2.12853925 |
| 16 | PRKCH | 2.11914172 |
| 17 | FER | 2.03960887 |
| 18 | MST1R | 1.94609172 |
| 19 | STK3 | 1.93999764 |
| 20 | PRKD2 | 1.93312734 |
| 21 | ERBB3 | 1.85472616 |
| 22 | NEK9 | 1.81499853 |
| 23 | PRKAA2 | 1.79486224 |
| 24 | MAPKAPK3 | 1.65993988 |
| 25 | LATS2 | 1.65934345 |
| 26 | PHKG1 | 1.64476495 |
| 27 | PHKG2 | 1.64476495 |
| 28 | FGFR4 | 1.55767225 |
| 29 | BCKDK | 1.45181388 |
| 30 | PIK3CA | 1.44930576 |
| 31 | BMPR2 | 1.41185414 |
| 32 | DMPK | 1.37186511 |
| 33 | PRPF4B | 1.31938721 |
| 34 | FRK | 1.31810963 |
| 35 | PIK3CG | 1.28249265 |
| 36 | LATS1 | 1.26395464 |
| 37 | MUSK | 1.23069618 |
| 38 | CDC42BPA | 1.19751794 |
| 39 | PDK2 | 1.19084365 |
| 40 | JAK1 | 1.17611211 |
| 41 | PINK1 | 1.17329238 |
| 42 | RIPK1 | 1.16803426 |
| 43 | MAPK7 | 1.09717541 |
| 44 | ICK | 1.09591729 |
| 45 | ZAK | 1.06538734 |
| 46 | MARK2 | 1.06263950 |
| 47 | MAPK4 | 1.03694867 |
| 48 | INSRR | 1.02797547 |
| 49 | PAK2 | 1.02657092 |
| 50 | PKN2 | 1.00573286 |
| 51 | SGK2 | 0.99725550 |
| 52 | MYLK | 0.99667778 |
| 53 | PDK4 | 0.98602667 |
| 54 | PDK3 | 0.98602667 |
| 55 | MAP3K7 | 0.98334172 |
| 56 | BLK | 0.97340827 |
| 57 | TRPM7 | 0.95238176 |
| 58 | MAP3K3 | 0.94334535 |
| 59 | FGFR3 | 0.94252101 |
| 60 | PRKAA1 | 0.90948347 |
| 61 | CAMK1 | 0.88942289 |
| 62 | PLK2 | 0.88572132 |
| 63 | SGK3 | 0.86296897 |
| 64 | BMX | 0.86040646 |
| 65 | EPHB2 | 0.85618459 |
| 66 | PTK2B | 0.84812948 |
| 67 | PDGFRB | 0.83839460 |
| 68 | ILK | 0.83539164 |
| 69 | PTK6 | 0.83057938 |
| 70 | PRKCE | 0.82356795 |
| 71 | RPS6KA2 | 0.81563260 |
| 72 | IRAK1 | 0.80919682 |
| 73 | GSK3A | 0.80692911 |
| 74 | WNK1 | 0.80422495 |
| 75 | MET | 0.79790210 |
| 76 | TESK1 | 0.78363858 |
| 77 | PRKD1 | 0.75376526 |
| 78 | PAK3 | 0.74878966 |
| 79 | SGK223 | 0.73859282 |
| 80 | SGK494 | 0.73859282 |
| 81 | LMTK2 | 0.70646095 |
| 82 | MAP2K3 | 0.70394215 |
| 83 | ROCK1 | 0.69913758 |
| 84 | PIM2 | 0.69554153 |
| 85 | LRRK2 | 0.67940871 |
| 86 | KIT | 0.67895714 |
| 87 | NLK | 0.66255150 |
| 88 | MAP2K4 | 0.65940978 |
| 89 | STK38 | 0.59875889 |
| 90 | NME1 | 0.58141362 |
| 91 | AKT3 | 0.57842048 |
| 92 | MAP2K1 | 0.57299171 |
| 93 | CAMK4 | 0.55418551 |
| 94 | RPS6KC1 | 0.53894526 |
| 95 | RPS6KL1 | 0.53894526 |
| 96 | JAK2 | 0.53335919 |
| 97 | MAP3K2 | 0.52506451 |
| 98 | TYK2 | 0.51461523 |
| 99 | KDR | 0.50643413 |
| 100 | MARK1 | 0.49622979 |
| 101 | FGFR1 | 0.48525644 |
| 102 | PKN1 | 0.47149992 |
| 103 | CLK1 | 0.46886737 |
| 104 | IRAK4 | 0.46010299 |
| 105 | PRKACG | 0.45152415 |
| 106 | RPS6KA6 | 0.44980021 |
| 107 | MAPK15 | 0.44673658 |
| 108 | AKT2 | 0.43858689 |
| 109 | ROCK2 | 0.42250233 |
| 110 | MAPK3 | 0.41472042 |
| 111 | INSR | 0.41434225 |
| 112 | TGFBR1 | 0.41385077 |
| 113 | ERBB4 | 0.40960633 |
| 114 | JAK3 | 0.40692877 |
| 115 | IKBKB | 0.39202826 |
| 116 | RET | 0.38827583 |
| 117 | PDPK1 | 0.38413046 |
| 118 | MTOR | 0.37921570 |
| 119 | CSK | 0.37833402 |
| 120 | MOS | 0.37083056 |
| 121 | PAK4 | 0.36849397 |
| 122 | HIPK2 | 0.35709557 |
| 123 | MAP3K11 | 0.34628947 |
| 124 | RPS6KA3 | 0.33749114 |
| 125 | CDK6 | 0.33558105 |
| 126 | IGF1R | 0.31647110 |
| 127 | PRKACB | 0.31547514 |
| 128 | PRKG1 | 0.31272913 |
| 129 | CAMK2G | 0.31240661 |
| 130 | ABL2 | 0.31060826 |
| 131 | PTK2 | 0.30917693 |
| 132 | MAP3K1 | 0.30434288 |
| 133 | MAPK12 | 0.30033698 |
| 134 | SRC | 0.29254954 |
| 135 | ABL1 | 0.29211071 |
| 136 | ADRBK1 | 0.28563116 |
| 137 | STK39 | 0.25101203 |
| 138 | NTRK1 | 0.25046342 |
| 139 | MAPK1 | 0.21625064 |
| 140 | MAPKAPK5 | 0.21555755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 5.00473359 |
| 2 | Protein digestion and absorption_Homo sapiens_hsa04974 | 3.64762388 |
| 3 | Malaria_Homo sapiens_hsa05144 | 3.51390059 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.20509182 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.06738604 |
| 6 | Focal adhesion_Homo sapiens_hsa04510 | 2.82432508 |
| 7 | Amoebiasis_Homo sapiens_hsa05146 | 2.42171465 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.41359395 |
| 9 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.15182861 |
| 10 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.02547946 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.88757666 |
| 12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.78906965 |
| 13 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.72438331 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64653417 |
| 15 | ABC transporters_Homo sapiens_hsa02010 | 1.63456478 |
| 16 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.61236145 |
| 17 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.58372455 |
| 18 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.53386441 |
| 19 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.46363444 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41874275 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.40582934 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.40116948 |
| 23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.27158246 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.23467198 |
| 25 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18525819 |
| 26 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.16616493 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15885686 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09976979 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08793659 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.07022183 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.04987270 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02328120 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.01592718 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98923885 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97422531 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97417946 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91028965 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 0.86989706 |
| 39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84935192 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83067588 |
| 41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82955858 |
| 42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82804738 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82371206 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80267340 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.79842408 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79395410 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.78072324 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77499209 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.76588991 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76515148 |
| 51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75768230 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73857256 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72909817 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.70331418 |
| 55 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68810542 |
| 56 | Pathways in cancer_Homo sapiens_hsa05200 | 0.68759939 |
| 57 | Melanoma_Homo sapiens_hsa05218 | 0.67549755 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.67312004 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66984704 |
| 60 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66168394 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.65522476 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.64234672 |
| 63 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63866041 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63825325 |
| 65 | Bladder cancer_Homo sapiens_hsa05219 | 0.63673586 |
| 66 | Prostate cancer_Homo sapiens_hsa05215 | 0.62938485 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61639987 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.61256139 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.61047120 |
| 70 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.60894691 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60879037 |
| 72 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60157614 |
| 73 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59958197 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59624829 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59338568 |
| 76 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58918589 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.58170129 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.57496067 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56179584 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.56151716 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.56116254 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56033859 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55938688 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55791732 |
| 85 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55557793 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54893492 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54376518 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53684509 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.53114635 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53023617 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.52944200 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52686672 |
| 93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51705618 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.51613484 |
| 95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51440588 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51106482 |
| 97 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.49685916 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49554061 |
| 99 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48763555 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48687896 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.48590168 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48075264 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47813991 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.47477632 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.47430405 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46779032 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46682973 |
| 108 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46000048 |
| 109 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45657798 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.44992818 |
| 111 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44935171 |
| 112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44692897 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.44623694 |
| 114 | Melanogenesis_Homo sapiens_hsa04916 | 0.44580138 |
| 115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43952151 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.43949425 |
| 117 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.43817870 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.43738111 |
| 119 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.43697617 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43260866 |
| 121 | Salmonella infection_Homo sapiens_hsa05132 | 0.43240640 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43181310 |
| 123 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42666316 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41565073 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.37976202 |
| 126 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37845762 |
| 127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37485298 |
| 128 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37417738 |
| 129 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36164101 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34086852 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33901373 |
| 132 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.33271705 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32568049 |
| 134 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32137059 |

